NCE Discovery and DARA BioSciences Join Forces to Develop New Therapies
CAMBRIDGE, England, Dec. 6, 2006–NCE Discovery Ltd (NCED), the specialist medicinal chemistry and drug design service provider, has entered into an agreement with US-based DARA BioSciences, Inc. to work together on the development of new drug target molecules.
DARA BioSciences discovers and develops small molecule treatments for metabolic and CNS diseases and, under the terms of the agreement, will have access to NCED’s full range of medicinal chemistry expertise, initially to address two specific drug targets. Financial terms of the agreement were not disclosed.
“This collaboration is another prime example of NCE Discovery’s successful operations as a service provider in the US pharmaceutical market,” said Chris Sharman, NCED’s CEO. “We welcome the opportunity to work with the team at DARA BioSciences to speed up the discovery and development of important new medicines.”
John Didsbury, Chief Scientific Officer at DARA BioSciences, commented: “We are looking forward to working with NCED and believe that the medicinal chemistry capabilities it brings to the collaboration will help tremendously with our development program of potential new therapies.”
NCE Discovery provides a range of specialist medicinal chemistry services to help its clients to accelerate their drug discovery programs, from initial planning through to target identification of clinical drug candidates.
For more information, contact Chris Sharman at NCE Discovery Ltd., 418 Cambridge Science Park, Milton Road, Cambridge. CB4 0PA Tel: +44 (0)1993 201801 Fax: +44 (0)1993 200401 Email: c.sharman@ncediscovery.com, www.ncediscovery.com
About NCE Discovery NCE Discovery Ltd provides a range of specialist medicinal chemistry services to the biotechnology sector in order to accelerate its clients’ drug discovery and development activities. The Company can support and design comprehensive medicinal chemistry programs - from hit finding through to pre-clinical development. These programs are designed and delivered by experienced medicinal chemists working in fully equipped laboratories, supported by expert computational chemistry using industry-leading software tools. Services offered by NCE Discovery include: * drug discovery program management, from early proof-of-concept studies through to delivery of candidate drugs * medicinal chemistry: hit identification through to lead optimisation * structure-based drug design including small molecule and protein modelling * screening collection design and enhancement * data handling and cheminformatics.
More information on NCE Discovery Ltd can be found at www.ncediscovery.com or info@ncediscovery.com
